Osaic Holdings’s Kindred Biosciences, Inc. KIN Stock Holding History

Osaic Holdings’s Portfolio KIN Stock Details KIN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-43,375	Closed	-$398K	–	7513
2021 Q2	$398K	Buy	43,375 +23,700	+120%	+$138K	﹤0.01%	3252
2021 Q1	$98K	Buy	19,675 +12,575	+177%	+$60.7K	﹤0.01%	4372
2020 Q4	$31K	Buy	7,100 +3,800	+115%	+$15.5K	﹤0.01%	4906
2020 Q3	$14K	Buy	3,300 +800	+32%	+$3.34K	﹤0.01%	5129
2020 Q2	$11K	Buy	2,500 +100	+4%	+$447	﹤0.01%	5155
2020 Q1	$10K	Buy	+2,400	New	+$20.4K	﹤0.01%	5031

Other funds holding KIN

CFO

CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return

Osaic Holdings's KIN Position: Q3 2021 in Review

Osaic Holdings sold out of Kindred Biosciences, Inc. (KIN) in Q3 2021, closing a stake of 43,375 shares — an estimated $398K sold.

Osaic Holdings first reported a position in KIN in Q1 2020 and held it in 6 quarters. The position peaked at $398K in Q2 2021. 1 fund tracked by Wall St. Rank holds KIN as of Q3 2021.

Osaic Holdings reported no remaining Kindred Biosciences, Inc. position as of Q3 2021 after selling out during the quarter.
Osaic Holdings sold 43,375 Kindred Biosciences, Inc. shares in Q3 2021, an estimated $398K.
Osaic Holdings first reported a position in Kindred Biosciences, Inc. in Q1 2020 and held it in 6 quarters.
Osaic Holdings's Kindred Biosciences, Inc. position peaked at $398K in Q2 2021.
1 fund tracked by Wall St. Rank held Kindred Biosciences, Inc. as of Q3 2021.

Based on Osaic Holdings's 13F filing for Q3 2021, filed 5 Nov 2021.